Oh, so specialized. Oh, so uniquely qualified. Oh, so responsive.

That’s OsoBio, a CMO that specializes in delivering injectable sterile liquid, suspension and lyophilized biologic and pharmaceutical products. OsoBio offers significant knowledge and experience in late-phase clinical products and successfully taking them to commercialization.

In the history of our Albuquerque, N.M., facility, OsoBio has manufactured more than 250 distinct commercial presentations in every major therapeutic category. OsoBio effectively manages the risks posed by potent and cytotoxic compounds and DEA schedule II-V substances.

Responsiveness, attention to detail and clear communication are the hallmarks of OsoBio’s client care. Our employees are industry veterans who provide innovative solutions to clients’ most difficult sterile projects.

To learn more about how OsoBio's knowledgeable and experienced team stands ready to manage your project, regardless of its size, please contact us.

OsoBio has been acquired by AMRI. Visit AMRIglobal.com to learn more.

 

OsoBio News